Cynosure Inc

Cynosure — Merger or Acquisition (March 2013)

31 slides from Cynosure's merger presentation, Mar 18, 2013

  1. Slide 1: Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies

    Exhibit18, Cynosure March 99.3 Signs 2013 Definitive Agreement to Acquire Palomar Medical Technologies

  2. Slide 2: Forward-Looking Statements

    Forward-Looking With profitability, neither looking research, third the combining detailed 2to place results parties, thepromises statements. undue from exception lack of theprojected the litigation, time of operations reliance impact product nor Statements to of These guarantees, time the synergies

  3. Slide 3: Additional Information About the Transaction

    Additional In and THE STATEMENT/PROSPECTUS INFORMATION. at Department Cynosure transaction. 8-K Palomar’s beneficially by the indicated This unlawful 3U.S. www.sec.gov connection security joint Palomar dated presentation Securities JOINT proxy prior above. and November directors Information holdings

  4. Slide 4: Today's Presenters

    Today’s Michael Joseph 4Tim Baker Caruso Presenters Davin Executive Chairman, Chairman, VicePresident President President,and and andCEO CEO CFOPalomar Cynosure Cynosure

  5. Slide 5: Transaction Overview

    Transaction Cynosure 50% Purchase Represents 23% Approximately New CEO President COO Pro 5Expected Forma cash premium Management and and consideration Chairman to and CFO to / Ownership: 50% an Overview close be acquire Vice attractive to accretive Tim 34% stock, Palomar’s in/Chairman Baker Board Mi

  6. Slide 6: Attractive Acquisition Rationale

    Transaction Complements Provides Strengthens Enhances Creates For Attractive Ownership Participation Broadens Opens 6Industry’s Cynosure’s Palomar’s new substantial new market intellectual acquisition broadest in cross-selling Rationale global inworld’s organic product shareholders: future sharehold

  7. Slide 7: Combination Creates Industry's Broadest Aesthetic Laser Portfolio

    Combination Both Installed Portfolio More Global Sales Direct Diversified Attractive Pro-forma 2012 GAAP Strong 7(1) Includes companies revenue in than operations balance profitability distribution more base spans financial 2012 80 geographic proceeds Creates patents growth: than ofsheet: laser reve

  8. Slide 8: Cynosure and Palomar: Innovation Leaders

    Cynosure Palomar The 8(1) Includes use of first created minimally picosecond laser fractional and created aesthetic proceeds Palomar hair new new removal technology invasive lasers technology markets from markets Have today in-the-money system laser cellulite Defined bybyfor has introducing lipolysi

  9. Slide 9: Significant Sales Opportunities in Light-Based Aesthetic Treatments

    Significant Sales ($ 9Source: in millions) of Medical Light-Based Market (inInsight, millions) Opportunities Device Inc. Worldwide Procedure Volume for Platforms By Application Light-Based Aesthetic Treatments

  10. Slide 10: Complementary Broad Differentiated Product Portfolio

    Complementary Broad Differentiated Fractional Picosecond Onychomycosis 2012 10 Revenue: laserlasers technology portfolio minimally Publicly Aesthetic product / entry Intense platform into Traded invasive Franchises low pulsed Companies price Advanced light segment (IPL) diode (PicoSure) heritage tec

  11. Slide 11: Pro Forma Worldwide Distribution of Professional Product Revenue

    Worldwide 2012 North 52% RoWAmerica 48% 11 52% Pro RoWForma Distribution 48% Professional Product Revenue

  12. Slide 12: Key Strengths of Combined Company

    321Key 87654Cellulite 12 Advanced Hair Intense Minimally Innovative Low-cost Intelligent Home-use Strengths removal reduction, pulsed non-ablative diode delivery consumer invasive PicoSure offranchise light Combined technology Laser systems technologies (IPL) picosecond market fractional covering li

  13. Slide 13: Case Study: Hair Removal

    1 Case Study: Launched 13 in September Hair Removal 2012

  14. Slide 14: Vectus Launched September 2012

    1 Vectus Launched State Skintel Advanced High Short-pulse Uniform Interchangeable Large Small Photon Fastest 14 of peak spot system melanin Recycling the Diode beams in contact power size art capability September on Graphic option Hair without optical spot the for cooling Removal sizes market maximu

  15. Slide 15: Palomar Leader in Hair Removal: Legacy and Factory Refurbished

    2 A Leader Legacy Factory Sold Replacement Next Launched Interchangeable Multiple High Non Advanced Treatment 15 ablative to generation peak average certain laser refurbished applications Q2 cooling tracking powers inand handpiece powers 2011 Intense countries handpieces IPL IPL ablative for softwar

  16. Slide 16: Leadership in Laser Lipolysis and Cellulite

    3 Leadership Laser First Current Long-lasting US: Europe: Cellulite Intelligent 16 Q1 launched lipolysis 2012 3rd 2011 affects energy generation reduction in 510(k) CE in for Minimally an 2006 Mark delivery removal estimated / Launch SmartLipo of / Launch cellulite and Invasive of85% unwanted dispos

  17. Slide 17: Laser-assisted SlimLipo and Fat Transfer

    3 Leadership Laser-assisted SlimLipo Addresses Single Fat Unique Higher High 17 transfer margin use graft filtering : fastest proprietary Selective system volume disposable inlipolysis Minimally mechanism growing survival Laser fiber system segment Induced Invasive tip and and with optimized more of

  18. Slide 18: Picosecond Tattoo Removal Platform

    4 Month Launched Initial Future: Picosecond Preserves Delivers 100x 3Under Before An 18Picosecond estimated shorter focus: development Other photothermal Post skin atlaser AAD pulse Removal Technology 20% 4aesthetic integrity Txexpected Annual of than for the of and applications ~10 current while 45

  19. Slide 19: Differentiated Tattoo Removal

    4 Differentiated *Company 19 estimates Tattoo based Removal on industry publications.

  20. Slide 20: Emerge Fractional Laser

    5 Emerge Easy Small Portable Low High Complements Pay Additional 20 per cost to ROI footprint use procedure non-ablative Fractional applications Botox Laser and fractional under fillersdevelopment tolaser build an aesthetic practice

  21. Slide 21: Advanced Semiconductor Diode Technology

    6 Advanced Under Semiconductor Key Very Up Ability Reliable Low More Compact Size High Speed 21 toattributes: Cost efficient powered average powerful 70% development toportable operate efficient Diode power energy diode devices material; for products Technology converting for means lasers source tho

  22. Slide 22: Advanced High-powered Diode Products

    6 Advanced High-powered Vectus Non-ablative Emerge Non-invasive SlimLipo Home PaloVia 22 use skin Diode fractional laser diode rejuvenation Products lipolysis hair laser removal system laser system

  23. Slide 23: Intelligent Delivery Systems: Skintel

    7 Intelligent Skintel The Enables Accurately Wirelessly Provides Intelligent Side-firing 23 onlyMelanin treatment additional FDA-cleared motion sets laser measures Delivery suggested •allows For outcomes and safety the Systems use temperature melanin greater melanin treatment with and toefficacy Ico

  24. Slide 24: Home Aesthetic Leadership Initiative

    8 Home Aesthetic Leadership Cynosure’s The Provides Low 24 first costUse FDA adiode market low through first Initiative cleared cost technology home-use leader innovation platform at-home over that forlaser Harmonious the can additional counter be clinically leveraged consumer device vision proven i

  25. Slide 25: Historical Product Revenue: Palomar and Cynosure

    Historical Palomar ($ $153.5 Cynosure Excludes Product in millions) Revenue $29.8MM Revenues CAGR: in royalty 13.1% 27.2%revenues from settlement of Candela/Syneron litigation

  26. Slide 26: Pro Forma Combined Total Revenue

    ProinForma Combined Total Product ($ (Totals 26 millions) revenue may revenue revenue Revenue not $234MM add $184MM information due to rounding) as of 12/31/2012

  27. Slide 27: Expected Post-Transaction Synergies and Balance Sheet

    Expected Public Board Administrative Management International Includes Acquisition Post Shares 27 transaction of company outstanding: transaction directors cost Synergies expected distribution Marketing synergies $8MM (pro expenses 22MM costs, forma) totobe$10MM change-of-control accretive Cash bala

  28. Slide 28: Combined Company Headquarters

    Combined Company Headquarters 28

  29. Slide 29: Cynosure's Track Record of Successful Acquisitions

    Cynosure’s Track Acquisitions Eleme ConBio Exclusive Opportunistically 29 record Medical (6/11): worldwide Successful in of RevLite (2/11): 2011: successful willdistribution continue SmoothShapes History andbusiness MedLite of to rights Integration evaluate development C Series for strategic PinPoin

  30. Slide 30: Combination Summary

    Combination Summary Comprehensive Seasoned Valuable Direct Best-in-class, Strong Momentum PicoSure Vectus, Home-use Ample 30 operations balance bandwidth ICON intellectual and management product with of Cellulaze worldwide and sheet product/technology Cynosure recent infor Emerge innine property par

  31. Slide 31: Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies

    Cynosure March 18,Signs 2013 Definitive Agreement to Acquire Palomar Medical Technologies

Cynosure — Merger or Acquisition (March 2013) on 6ix